Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Anne Lienhart"'
Autor:
Ngoc Anh Thu Nguyen, Pascal Auquier, Any Beltran Anzola, Roseline D’oiron, Thierry Lambert, Céline Falaise, Christine Biron, Anne Lienhart, Jenny Goudemand, Antoine Rauch, Bénédicte Wibaut, Sabine Marie Castet, Dominique Desprez, Annie Harroche, Natalie Stieltjes, Annie Borel-Derlon, Marc Trossaërt, Amandine Celli, Benoît Guillet, Sophie Bayart, Marie-Anne Bertrand, Alexandra Fournel, Guillaume Mourey, Valérie Gay, Pierre Chamouni, Emmanuelle DE Raucourt, Birgit Frotscher, Michèle Martin, Mathieu Puyade, Brigitte Tardy, Stéphane Vanderbecken, Fabienne Genre-Volot, Philippe Nguyen, Benoît Polack, Caroline Oudot-Challard, Stéphane Girault, Annelise Voyer, Aurélien Lebreton, Abel Hassoun, Philippe Moreau, Pierre-Simon Rohrlich, Karine Baumstarck, Mohamed Boucekine, Vanessa Milien, Natacha Rosso, Clemence Tabele, Marie Viprey, Nicolas Giraud, Thomas Sannie, Hervé Chambost, Noémie Resseguier
Publikováno v:
HemaSphere, Vol 7, p e623777c (2023)
Externí odkaz:
https://doaj.org/article/35f0ccb00974432f92e9847dd92e5503
Autor:
Yesim Dargaud, Anne Lienhart, Maissaa Janbain, Sandra Le Quellec, Nathalie Enjolras, Claude Negrier
Publikováno v:
Haematologica, Vol 103, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/b91411ae5e824cb7954bd95f3c9ba4e5
Autor:
Stéphanie Désage, Yesim Dargaud, Sandrine Meunier, Sandra Le Quellec, Anne Lienhart, Claude Negrier, Christophe Nougier, Lucia Rugeri
Publikováno v:
Haemophilia. 28:301-307
In patients with FXI deficiency, the risk of surgery-related bleeding is poorly correlated with plasma FXI activity (FXI:C); the latter can therefore not be used as a reliable predictor of bleeding in surgeries.The aim of this retrospective study was
Autor:
Ngoc Anh Thu, Nguyen, Pascal, Auquier, Any, Beltran Anzola, Roseline, d'Oiron, Christine, Biron-Andréani, Anne, Lienhart, Antoine, Rauch, Karine, Baumstarck, Mohamed, Boucekine, Vanessa, Milien, Natacha, Rosso-Delsemme, Clemence, Tabele, Nicolas, Giraud, Thomas, Sannié, Hervé, Chambost, Noémie, Resseguier, Pierre-Simon, Rohrlich
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(6)
Health of people with severe haemophilia (PwSH) improves thanks to the advancements in haemophilia care, giving them more opportunities in occupational integration. However, there is little literature on the occupational integration of PwSH.The main
Publikováno v:
Therapies. 76:23-29
Prophylaxis treatment is considered as the reference approach for children with severe haemophilia A or B. However, no consensus about the best prophylaxis protocol has yet been identified in term of dosage and timing of infusions. Guidelines were dr
Autor:
Pierre-Simon Rohrlich, Pierre Boisseau, Mathilde Fretigny, Amy Dericquebourg, Yohann Jourdy, Christine Vinciguerra, Catherine Ternisien, Ségolène Claeyssens, Anne Lienhart, Claude Negrier
Publikováno v:
Haemophilia. 26:847-854
Introduction With current molecular diagnosis, about 1 to 5% of haemophilia A (HA) patients remain genetically unresolved. In these cases, deep intronic variation or structural variation disrupting the F8 gene could be causal. Aim To identify the cau
Publikováno v:
Haemophilia
Aim For patients with severe haemophilia A, guidelines recommend prophylactic treatment with FVIII, with dose calculations targeting a predetermined FVIII trough level. However, this pharmacokinetic (PK) approach is suboptimal, with some patients exp
Publikováno v:
Haemophilia. 25:1020-1027
Introduction Recombinant FVIIa (rFVIIa) is widely used to manage bleeding risk during and after surgery in patients with haemophilia complicated by inhibitors. In the postoperative period, rFVIIa must be delivered frequently and regularly to maintain
Autor:
Pierre Chelle, Brigitte Tardy-Poncet, Hervé Chambost, Pauline Damien, Fabienne Genre‐Volot, Michel Cournil, Aurélie Montmartin, Michèle Piot, Claire Morin, Anne Lienhart
Publikováno v:
Haemophilia. 25:343-348
The thrombin generation (TG) assay evaluates haemostatic balance, which is influenced by the levels of many coagulation factors and inhibitors. Our objective was to identify the determinant factors of TG in haemophilia A (HA) and haemophilia B (HB) p
Publikováno v:
Haemophilia. 27
Introduction Lightening the injection burden is commonly believed to improve prophylaxis adherence. Efmoroctocog alfa (rFVIIIFc) is the first recombinant FVIII-Fc fusion protein available in France. This clotting factor with an extended half-life cou